Moreover, introduction of p53 resensitize MCB1 overexpression hepatoma cells to CDDP treatment (Figure S7E,F, Supporting Information), which further suggesting that p53 was responsible for MCB1 mediated conventional chemoresistance. The gene discussed is TP53; the disease is hepatocellular carcinoma.